| PERIOD ENDING | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | 26-Sep-08 | | Total Revenue | 385,400 | 361,700 | 408,300 | 424,100 | | Cost of Revenue | 217,900 | 201,900 | 238,500 | 261,900 | | | Gross Profit | 167,500 | 159,800 | 169,800 | 162,200 | | | Operating Expenses | | Research Development | 66,300 | 69,500 | 71,900 | 74,000 | | Selling General and Administrative | 66,600 | 68,800 | 67,300 | 66,600 | | Non Recurring | 4,100 | 6,700 | 17,700 | 997,400 | | Others | 6,000 | 6,000 | 6,500 | 6,200 | | | | Total Operating Expenses | 143,000 | 151,000 | 163,400 | 1,144,200 | | | | Operating Income or Loss | 24,500 | 8,800 | 6,400 | (982,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,200 | 4,700 | (6,200) | 1,000 | | Earnings Before Interest And Taxes | 30,700 | 13,500 | 200 | (981,000) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 30,700 | 13,500 | 200 | (981,000) | | Income Tax Expense | 15,000 | 7,000 | (12,600) | 17,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,700 | 6,500 | 12,800 | (998,500) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,700 | 6,500 | 12,800 | (998,500) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,700 | $6,500 | $12,800 | ($998,500) |
|
2.03% Nasdaq 
Income Statement
